The Symposium on Emerging Treatments and Advances in Novel Cancer Therapies for Practicing Physicians and Healthcare Professionals covers topics such as:
- Breast cancer treatment with integration of novel cytotoxic agents
- Lung cancer targeted therapy based on histology along with predictive and prognostic markers
- Treatment options in the management of non-colorectal gastrointestinal cancer such as pancreatic cancer, esophagogastric cancer, neuroendocrine cancer and hepatocellular carcinoma
- The impact of combination therapy for colorectal cancer
- Treatment options for lymphoma
- Regimens in the treatment of leukemia
- Therapeutic options for prostate cancer and renal cell carcinoma
- Standard therapy and novel agent combinations in the treatment of multiple myeloma
- Therapeutic options in the management of malignant melanoma
- Standard chemotherapy and novel therapeutic options for ovarian and gynecologic malignancies
- Supportive cancer care in targeted therapy
- The role of pharmacogenomics in individualized therapies
- Symptom management issues in targeted chemotherapy
- Reimbursement issues in the management of cancer treatment
The Symposium on Emerging Treatments and Advances in Novel Cancer Therapies for Practicing Physicians and Healthcare Professionals brings together medical oncologists, hematologists, surgical oncologists, radiation oncologists, pharmacists, researchers, physician assistants, registered nurses, fellows in training and nurse practitioners.
